Reduced risk of gastrointestinal bleeding associated with eupatilin in aspirin plus acid suppressant users: nationwide population-based study

CONCLUSIONS: Eupatilin administration for ≥ 3 months showed additional preventive effect on GI bleeding in concomitant aspirin and acid suppressant users. Thus, cotreatment with eupatilin with a duration of 3 months or longer is recommended for reducing GI bleeding among aspirin plus acid suppressant users.PMID:38092556 | DOI:10.3904/kjim.2023.324
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Source Type: research